1,25 dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis

被引:53
作者
Vidyarani, M. [1 ]
Selvaraj, P. [1 ]
Jawahar, M. S. [1 ]
Narayanan, P. R. [1 ]
机构
[1] Indian Council Med Res, Tuberculosis Res Ctr, Madras 600031, Tamil Nadu, India
关键词
cytokines; M; tuberculosis; 1,25 dihydroxyvitamin D-3;
D O I
10.1016/j.cyto.2007.08.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1, 25 Dihydroxyvitamin D-3 (1, 25(OH)(2) D-3) has gained significant importance in tuberculosis with regard to its immunoregulatory activities. Our aim was to evaluate the effect of 1,25(OH)(2) D-3 on cytokine response to Mycobacterium tuberculosis antigens in pulmonary tuberculosis. Peripheral blood mononuclear cells obtained from 60 healthy controls and 52 pulmonary tuberculosis patients were cultured with culture filtrate antigen (CFA) of M. tuberculosis and live M. tuberculosis with and without 1, 25(OH)(2) D-3 (10(-9) 10(-8) and 10(-7) M concentrations). The culture supernatants were used to estimate IL-8, IL-6, TGF-beta, IL-10, IFN-gamma, IL-12p40, IL-2, IL-4 and IL-5 levels by ELISA. 1, 25 Dihydroxyvitamin D-3 significantly suppressed IL-12p40 and IFN-gamma production in response to CFA and live M. tuberculosis with a maximum suppression at 10(-7) M concentration (p<0.0001). In CFA stimulated cultures, addition of 1, 25(OH)(2), significantly suppressed IL-8, IL-6 and IL-10 whereas the IL-2 levels were significantly increased in controls. It variably influenced the D-3 Th2 cytokines, showing an increased trend for IL-4 and suppressed IL-5 levels. We report that 1, 25(OH)(2) D-3 differentially modulates production of cytokines in response to M. tuberculosis antigens by predominantly suppressing IL-12p4O and IFN-gamma production in a dose dependent manner. Our results suggest a role for vitamin D in restricting acquired immune response against tuberculosis by regulating cytokine production. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:128 / 134
页数:7
相关论文
共 37 条
[1]   CYTOKINE PRODUCTION AT THE SITE OF DISEASE IN HUMAN TUBERCULOSIS [J].
BARNES, PF ;
LU, SZ ;
ABRAMS, JS ;
WANG, E ;
YAMAMURA, M ;
MODLIN, RL .
INFECTION AND IMMUNITY, 1993, 61 (08) :3482-3489
[2]   IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice [J].
Biedermann, T ;
Zimmermann, S ;
Himmelrich, H ;
Gumy, A ;
Egeter, A ;
Sakrauski, AK ;
Seegmüller, I ;
Voigt, H ;
Launois, P ;
Levine, AD ;
Wagner, H ;
Heeg, K ;
Louis, JA ;
Röcken, M .
NATURE IMMUNOLOGY, 2001, 2 (11) :1054-1060
[3]  
Bonecini-Almeida MG, 1998, J IMMUNOL, V160, P4490
[4]   1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells [J].
Boonstra, A ;
Barrat, FJ ;
Crain, C ;
Heath, VL ;
Savelkoul, HFJ ;
O'Garra, A .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :4974-4980
[5]   1,25(OH)2D3 PRODUCTION BY LYMPHOCYTE-T AND ALVEOLAR MACROPHAGES RECOVERED BY LAVAGE FROM NORMOCALCEMIC PATIENTS WITH TUBERCULOSIS [J].
CADRANEL, J ;
GARABEDIAN, M ;
MILLERON, B ;
GUILLOZO, H ;
AKOUN, G ;
HANCE, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) :1588-1593
[6]   Effect of vitamin D3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis [J].
Chandra, G ;
Selvaraj, P ;
Jawahar, MS ;
Banurekha, VV ;
Narayanan, PR .
JOURNAL OF CLINICAL IMMUNOLOGY, 2004, 24 (03) :249-257
[7]   Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3 -: Involvement of NF-κB downregulation in transcriptional repression of the p40 gene [J].
D'Ambrosio, D ;
Cippitelli, M ;
Cocciolo, MG ;
Mazzeo, D ;
Di Lucia, P ;
Lang, R ;
Sinigaglia, F ;
Panina-Bordignon, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01) :252-262
[8]  
DING A, 1990, J IMMUNOL, V145, P940
[9]   Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB) [J].
Dlugovitzky, D ;
Bay, ML ;
Rateni, L ;
Fiorenza, G ;
Vietti, L ;
Farroni, MA ;
Bottasso, OA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (03) :343-349
[10]  
FLYNN JL, 1995, J IMMUNOL, V155, P2515